| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/10/267:00 AM | -$0.83 | -$0.74GAAP | +10.8% | +4% | $0.40M | $0 | -100% | — | |
| Q2 '26 | 8/6/267:00 AM | -$0.82 | -$0.81GAAP | +1.2% | +24% | $6.96M | $0 | -100% | — | |
| Q1 '26 | 5/7/267:00 AM | -$0.84 | -$0.75GAAP | +10.7% | -1% | $3.47M | $0 | -100% | — | |
| Q4 '25 | 3/10/267:00 AM | -$0.82 | -$0.77GAAP | +6.1% | -5% | $9.94M | $0 | -100% | — | |
| Q2 '25 | 8/7/257:00 AM | -$0.85 | -$1.07GAAP | -25.9% | -57% | — | $0 | — | — | |
| Q1 '25 | 5/8/257:00 AM | -$0.83 | -$0.74GAAP | +10.8% | +14% | — | $0 | — | — |
GAAP = diluted EPS as filed with the SEC.